secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2023-07-05T23:59:59+00:00
Accession:  0001558370-23-011705
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health shareholders approve reverse stock split authorization, increase authorized shares to 950M
--------------------------------------------------------------------------------

- Shareholders approved increase in authorized common shares from 900M to 950M (For: 329.7M, Against: 154.7M).
- Board authorized a reverse stock split at ratio between 1-for-2 and 1-for-15, effective within 12 months (For: 388.4M, Against: 95.9M).
- 2023 Equity Incentive Plan and 2023 Employee Stock Purchase Plan approved; ESPP first purchase period starts July 1, 2023.
- Officer liability exculpation provision added to charter as permitted by Delaware law (For: 370.3M, Against: 55.3M).
- All seven director nominees elected; Marcum LLP ratified as auditor for FY 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023011705/0001558370-23-011705-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023011705/nutx-20230629x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011705

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer